Volume 128, Issue 2, Pages 297-303 (February 2005) The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis Christophe Corpechot, Fabrice Carrat, Abbas Bahr, Yves Chrétien, Renée-Eugénie Poupon, Raoul Poupon Gastroenterology Volume 128, Issue 2, Pages 297-303 (February 2005) DOI: 10.1053/j.gastro.2004.11.009 Copyright © 2005 American Gastroenterological Association Terms and Conditions
Figure 1 The PBC multistate Markov model. Gastroenterology 2005 128, 297-303DOI: (10.1053/j.gastro.2004.11.009) Copyright © 2005 American Gastroenterological Association Terms and Conditions
Figure 2 Predicted percentages of UDCA-treated patients with PBC in each disease state for a subsequent 20-year period. (A) Patients treated from stages 1–2 and (B) patients treated from stages 3–4. The probability of each state is represented graphically as an area. Gastroenterology 2005 128, 297-303DOI: (10.1053/j.gastro.2004.11.009) Copyright © 2005 American Gastroenterological Association Terms and Conditions
Figure 3 Predicted survival rates with and without OLT of UDCA-treated patients with PBC compared with those of a control population matched for age, sex, and follow-up period and those predicted by the updated Mayo model. Gastroenterology 2005 128, 297-303DOI: (10.1053/j.gastro.2004.11.009) Copyright © 2005 American Gastroenterological Association Terms and Conditions
Figure 4 Predicted survival rates with and without OLT of UDCA-treated patients with PBC according to (A) early and (B) late histologic stages. Gastroenterology 2005 128, 297-303DOI: (10.1053/j.gastro.2004.11.009) Copyright © 2005 American Gastroenterological Association Terms and Conditions